There are 2789 resources available
349P - The amount of cancer stem cells and the sensitivity to anticancer drugs in glioblastoma primary cell culture
Presenter: Olga Susova
Session: ePoster Display
350P - Molecular profiling of tumor tissue and tumor-derived cell lines in patients with glioblastoma
Presenter: Tatiana Nasedkina
Session: ePoster Display
351P - Impact of time to initiation post-operative adjuvant chemo-radiation in glioblastoma multiform: A systematic review
Presenter: Sudibio Sudibio
Session: ePoster Display
440P - Response to BRAF inhibitors combined with anti-EGFR after previous anti-EGFR exposure for BRAF V600E mutant metastatic colorectal cancer patients
Presenter: Emilie Hafliger
Session: ePoster Display
441P - A study of vemurafenib and cetuximab in combination with FOLFIRI for patients with BRAF V600E-mutated advanced colorectal cancer (NCT03727763): Preliminary results
Presenter: Zhan Wang
Session: ePoster Display
442P - A phase I-II multicenter trial with avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients. GEMCAD 16-02 (AVEVAC trial)
Presenter: Marta Español-Rego
Session: ePoster Display
443P - EMERGE: A phase II trial assessing the efficacy of domatinostat plus avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal cancers – phase IIA dose finding
Presenter: Elizabeth Cartwright
Session: ePoster Display
444P - Prevalence of NTRK1/2/3 fusions in dMMR/MSI metastatic colorectal cancer
Presenter: Magali Svrcek
Session: ePoster Display
465P - Identification of actionable alterations in primary colorectal tumors using NGS-based comprehensive genomic profiling
Presenter: Alfred KY Lam
Session: ePoster Display
466P - Landscape of HER2 alterations in 5786 Chinese patients with colorectal cancer
Presenter: Xiaoyun Li
Session: ePoster Display